Mitochondrial DNA in liver inflammation and oxidative stress

Area of Science:

• Hepatology
• Mitochondrial Biology
• Immunology

Background:

• Liver function relies on mitochondria for ATP production, crucial for biosynthesis and detoxification.
• Hepatic disorders frequently involve significant mitochondrial dysfunction, including damage and release of mitochondrial DNA (mtDNA).
• Released mtDNA acts as damage-associated molecular patterns (DAMPs), initiating inflammatory responses via TLR9, inflammasome, and STING pathways.

Purpose of the Study:

• To review alterations in mitochondrial DNA (mtDNA) during liver injury.
• To elucidate the mechanisms of mtDNA-mediated liver inflammation and oxidative stress.
• To highlight the role of mtDNA in hepatitis B virus (HBV)-related liver injury and hepatocellular carcinoma (HCC).

Main Methods:

• Literature review of studies on mitochondrial dysfunction in liver disease.
• Analysis of mechanisms linking mtDNA release to inflammatory pathways (TLR9, inflammasomes, STING).
• Examination of mtDNA's role in HBV infection and HCC pathogenesis.

Main Results:

• Mitochondrial dysfunction is a hallmark of hepatic disorders, characterized by mtDNA damage, depletion, and extracellular release.
• Extracellular mtDNA triggers innate immune responses, exacerbating hepatocellular damage and potentially causing remote organ injury.
• mtDNA plays a significant role in the pathogenesis of HBV-induced liver injury and the development of HCC.

Conclusions:

• Mitochondrial DNA alterations are critical drivers of liver inflammation and oxidative stress in various hepatic conditions.
• Targeting mtDNA-mediated inflammatory pathways may offer therapeutic strategies for liver diseases.
• Understanding mtDNA's role is essential for managing HBV-related liver injury and HCC.